probenecid has been researched along with Hyperbilirubinemia, Hereditary in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Hyperbilirubinemia, Hereditary: Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, MH | 1 |
| Redegeld, FA | 1 |
| Koster, AS | 1 |
| Noordhoek, J | 1 |
| de Haan, JG | 1 |
| Oude Elferink, RP | 1 |
| Jansen, PL | 1 |
1 other study available for probenecid and Hyperbilirubinemia, Hereditary
| Article | Year |
|---|---|
Hepatic, intestinal and renal transport of 1-naphthol-beta-D-glucuronide in mutant rats with hereditary-conjugated hyperbilirubinemia.
Topics: Animals; Bile; Glucuronates; Hyperbilirubinemia, Hereditary; Intestine, Small; Kidney; Liver; Male; | 1989 |